With the world's population ageing, the incidence of Parkinson's disease (PD) is on the rise.
In recent years, inflammatory processes have emerged as prominent contributors to the …

Novel, neuroprotective uses of Copaxone (generic name: glatiramer acetate—GA) are being
examined, primarily in neurological conditions involving cognitive decline. GA is a well …

Parkinson's disease (PD) is a progressive neurodegenerative disorder. The classical
behavioral defects of PD patients involve motor symptoms such as bradykinesia, tremor, and …

Immunity refers to the body's defense mechanism to protect itself against illness or to
produce antibodies against pathogens. Senescence is a cellular phenomenon that …

T cells are key mediators of both humoral and cellular adaptive immune responses, and
their role in Parkinson's disease (PD) is being increasingly recognized. Several lines of …

Neuroinflammation represents a common trait in the pathology and progression of the major
psychiatric and neurodegenerative disorders. Neuropsychiatric disorders have emerged as …

Parkinson's disease is the second most common neurodegenerative disease. Researchers
have shown that oxidative stress and apoptosis play an important role in the Parkinson's …

Accumulation of alpha-synuclein (αSyn) protein in neurons is a renowned pathological
hallmark of Parkinson's disease (PD). In addition, accumulating evidence indicates that …

There is growing interest in the use of natural products for the treatment of Parkinson's
disease (PD). Mucuna pruriens has been used in the treatment of humans with PD. The goal …

Loss of nigrostriatal dopamine (DA) in Parkinson's disease results in over‐
activation/bursting of the subthalamic nucleus (STN). The STN projects to the substantia …